OGN:NYSE
Organon & Co
$13.87
arrow_upward
+0.58%(+0.080) 1D
$13.87
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:05 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
$13.80
High
$13.87
Low
$13.78
Mkt. cap
3.64B
Avg. vol.
2.30M
Volume
3.95M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
18.04
52-wk high
$13.88
52-wk low
$5.69
EPS
$0.77
Beta
1.53
Shares outstanding
262.62M
No. of employees
10K
Open
$13.80
High
$13.87
Low
$13.78
Mkt. cap
3.64B
Avg. vol.
2.30M
Volume
3.95M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
18.04
52-wk high
$13.88
52-wk low
$5.69
EPS
$0.77
Beta
1.53
Shares outstanding
262.62M
No. of employees
10K
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
Organon (OGN) Highlights Successful Biosimilar Switch Study at A
Investing.com
·
8 hours ago
Organon earnings on deck as Sun Pharma merger awaits approval
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10K
Founded1923
HeadquartersJersey City, New Jersey, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com